Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: Rationale and design of the randomised TROFI II study

2016-07-01

EuroIntervention , Volume 12 - Issue 4 p. 482- 489

Additional Metadata
Keywords	Absorb BVS, Bioresorbable vascular scaffold, Drug-eluting stent, Optical frequency domain imaging, ST-elevation myocardial infarction
Persistent URL	doi.org/10.4244/EIJY15M08_03, hdl.handle.net/1765/96998
Journal	EuroIntervention
Organisation	Erasmus MC: University Medical Center Rotterdam
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Räber, L., Onuma, Y., Brugaletta, S., Garcia-Garcia, H., Backx, B., Iiguez, A., … Windecker, S. (2016). Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: Rationale and design of the randomised TROFI II study. EuroIntervention, 12(4), 482–489. doi:10.4244/EIJY15M08_03

Publication